Discover Rhythm Pharmaceuticals’ Q3 2025 earnings insights, IMCIVREE launch updates, regulatory milestones, and global growth plans.

As cyber-threats evolve, so must our mindset. In his recent article at SC Media, Jim Routh (an esteemed Institute for ...

Artificial intelligence is one of the fastest-growing and highest-paying fields today. The continued digitization of ...

In the European Union (EU) Member States, QDENGA is indicated for the prevention of dengue disease in individuals from four years of age and should be administered subcutaneously as a 0.5 mL dose at a ...

I 'm a big fan of Python for data analysis, but even I get curious about what else is available. R has long been the go-to ...

APL is fusing its analytic and cutting-edge AI capabilities into a forward-leaning incubator, known as GenWar Lab, that ...

Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not ...

A systematic review published today in Psychedelics by Mr. James Gattuso and colleagues at the Florey Institute of Neuroscience and Mental Health synthesizes clinical and preclinical evidence on ...

There is decreased risk for hospitalization in patients with heart failure who receive a high-dose inactivated influenza vaccine.

Objectives To evaluate the long-term efficacy of remote ischaemic postconditioning (RIPC) on functional outcomes in patients ...

Data from an exploratory analysis of the pivotal phase 3 MIRASOL trial (NCT04209855) were recently unveiled at the 2025 European Society for Medical Oncology (ESMO) Congress, opening a broader ...

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment was well tolerated ...